Firebrick Pharma Director Increases Shareholding

Firebrick Pharma Limited (AU:FRE) has released an update.

Firebrick Pharma Limited has notified the ASX of a change in the indirect interest of director Stephen Francis Goodall, with S & R Goodall Super Pty Ltd acquiring 181,818 ordinary fully paid shares for $10,000. The acquisition was part of the company’s Share Purchase Plan, resulting in S & R Goodall Super Pty Ltd holding a total of 711,818 shares post-change.

For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.